Clindamycin and nicotinic neuromuscular transmission.


Upon clindamycin treatment a patient with Parkinson's disease showed marked tremor improvement which may be explained by clindamycin's ability to inhibit in-vitro nicotinergic, but not muscarinic signal transmission.

Cite this paper

@article{Schulze1999ClindamycinAN, title={Clindamycin and nicotinic neuromuscular transmission.}, author={J. Schulze and M. Toepfer and K C Schroff and S Aschhoff and John Remien and Wolfgang Mueller-Felber and Steven P. Endres}, journal={Lancet}, year={1999}, volume={354 9192}, pages={1792-3} }